Sernova Biotherapeutics Inc Share Price
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Toronto S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 0.1050 CAD | 0.00% |
|
-22.22% | -19.23% |
| Market Cap | 3.97Cr 2.83Cr 2.47Cr 2.33Cr 2.12Cr 271.61Cr 3.98Cr 28Cr 11Cr 138.09Cr 11Cr 10Cr 444.32Cr | P/E 2026 * |
-4.2x | P/E 2027 * | -3.5x |
|---|---|---|---|---|---|
| Enterprise Value | 3.97Cr 2.83Cr 2.47Cr 2.33Cr 2.12Cr 271.61Cr 3.98Cr 28Cr 11Cr 138.09Cr 11Cr 10Cr 444.32Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 15.9x |
| Free-Float |
89.49% | Yield 2026 * |
-
| Yield 2027 * | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| SVA | End-of-day quote | |
Toronto S.E.
| SVA | Delayed | |
|
OTC Markets
| SEOVF | Delayed | |
|
Xetra
| PSH0 | Delayed | |
|
Tradegate
| PSH0 | Real-time | |
|
Deutsche Boerse AG
| PSH0 | Delayed | |
|
Boerse Muenchen
| PSH0 | Real-time | |
|
Börse Stuttgart
| PSH0 | Delayed |
| 1 week | -22.22% | ||
| Current month | -4.55% | ||
| 3 months | -34.38% | ||
| 6 months | -30.00% | ||
| Current year | -19.23% |
| 1 week | 0.1 |  | 0.14 |
| 1 month | 0.1 | | 0.15 |
| Current year | 0.1 | | 0.2 |
| 1 year | 0.1 | | 0.2 |
| 3 years | 0.1 | | 0.83 |
| 5 years | 0.1 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
Steven Sangha
BRD | Director/Board Member | - | 24/04/2023 |
David Paterson
BRD | Director/Board Member | - | 01/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/07/26 | Sell | Company | -1,15,000 | 0.0305% | ||
| 22/05/26 | Option | Chairman | 2,28,912 | 0.0658% | ||
| 22/05/26 | Option | Director | 2,60,000 | 0.0748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -22.22% | -41.67% | -86.54% | 2.83Cr | |
| -1.79% | -0.16% | -27.19% | -6.17% | 11TCr | |
| -0.77% | +1.88% | -24.84% | -2.00% | 1.16TCr | |
| +1.48% | -2.06% | +90.83% | +116.88% | 965.76Cr | |
| +0.75% | +2.06% | -52.06% | -71.12% | 402.41Cr | |
| +0.39% | +0.36% | -28.86% | +21.76% | 234.35Cr | |
| +5.55% | +5.18% | -7.94% | -63.46% | 221.97Cr | |
| +4.97% | +4.82% | - | - | 193.32Cr | |
| +0.72% | +1.95% | -20.50% | -29.27% | 152.83Cr | |
| Average | +1.26% | +0.80% | -14.03% | -14.99% | 1.54TCr | |
| Weighted average by Cap. | -1.13% | +0.08% | -19.04% | +0.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 25L 17.85L 15.56L 14.69L 13.34L 17Cr 25.1L 1.76Cr 67.92L 8.71Cr 67.04L 65.55L 28Cr |
| Net income | -1.13Cr -80.67L -70.34L -66.42L -60.31L -77Cr -1.13Cr -7.96Cr -3.07Cr -39Cr -3.03Cr -2.96Cr -126.62Cr | -1.39Cr -99.23L -86.52L -81.7L -74.19L -95Cr -1.4Cr -9.79Cr -3.78Cr -48Cr -3.73Cr -3.64Cr -155.76Cr |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | CA$0.1050 | 0.00% | 2,57,427 |
| 17/26/17 | CA$0.1050 | 0.00% | 1,63,786 |
| 16/26/16 | CA$0.1050 | +5.00% | 1,98,957 |
| 15/26/15 | CA$0.1000 | -9.09% | 9,83,178 |
| 14/26/14 | CA$0.1100 | -18.52% | 12,27,009 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.1050CAD
Average target price
1.000CAD
Spread / Average Target
+852.38%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
